Status: current, Primitive. Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3858363017 | Brolucizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3858364011 | Brolucizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Brolucizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Brolucizumab | Has disposition | Vascular endothelial growth factor receptor antagonist | true | Inferred relationship | Some | ||
| Brolucizumab | Is a | Vascular endothelial growth factor receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Brolucizumab only product | Has active ingredient | True | Brolucizumab | Inferred relationship | Some | 1 |
| Brolucizumab-containing product | Has active ingredient | True | Brolucizumab | Inferred relationship | Some | 1 |
| Brolucizumab-containing product in parenteral dose form | Has active ingredient | True | Brolucizumab | Inferred relationship | Some | 1 |
| Brolucizumab only product in parenteral dose form | Has active ingredient | True | Brolucizumab | Inferred relationship | Some | 1 |
| Brolucizumab 120 mg/mL solution for injection | Has precise active ingredient | True | Brolucizumab | Inferred relationship | Some | 1 |
| Brolucizumab 120 mg/mL solution for injection | Has BoSS | True | Brolucizumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
Description inactivation indicator reference set
FHIR